Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice

Overview of attention for article published in Frontiers in oncology, November 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,251 followers.

RT @yolisu: Happy to share with you about our new research focusing on safety and efficacy of immunotherapy in ESRD patient. #immunothera…

RT @yolisu: Happy to share with you about our new research focusing on safety and efficacy of immunotherapy in ESRD patient. #immunothera…

Happy to share with you about our new research focusing on safety and efficacy of immunotherapy in ESRD patient. #immunotherapy #ESRD #mUC https://t.co/vu03WTH82u

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.